Nohla Therapeutics

About:

Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.

Website: https://nohlatherapeutics.com/

Twitter/X: nohlatx

Top Investors: Alexandria Venture Investments, ARCH Venture Partners, Fidelity, UTEC - The University of Tokyo Edge Capital Partners, 5AM Ventures

Description:

Nohla Therapeutics' singular passion is the development of best-in-class ex vivo expanded universal donor cellular therapies to transform the treatment of patients with cancer and other life threatening illnesses. Our products are manufactured and cryopreserved on an ongoing basis allowing for a bank of doses that are available for immediate (on demand) use. This is tremendously advantageous with regards to the ease and timing of treatment, the ability to provide repeated dosing for immune-oncology indications and reduction in patient risk and cost relative to other cell therapies.